The problem here isn’t Costello. The problem here is that OTC Markets gave the impression certain criteria had been met to allow this to trade freely again.
It is a bit unreasonable to expect an investor to go independently verify a company is compliant to trade on the tier they’re on when there are regulatory bodies to enforce that.
OTC Markets started moving tickers around without the right criteria being met, misleading investors.